| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/17/2008 | US20080089843 Use of biomarkers of inflammation as indicators of drug efficacy |
| 04/17/2008 | US20080089810 Universal Regulatory Apparatus for Controlled Environments for Use with Added Sensors and Analyzers |
| 04/17/2008 | US20080089808 For treating hematological, cytological, or histological specimens; processing stations, lifting device, controllers |
| 04/17/2008 | US20080088820 Sensing systems and methods for differentiating between different cellular blood species during extracorporeal blood separation or processing |
| 04/17/2008 | US20080087852 Positronium-mediated method for identifying a contaminant gas in a gaseous mixture |
| 04/17/2008 | US20080087585 Sorting particles |
| 04/17/2008 | US20080087555 enables measurement independently of baseline drift and/or provides a detection method that has a raised sensitivity with reference to known methods; detectable product that is enriched before measurement |
| 04/17/2008 | US20080087226 Animal litter having the property of detecting diabetes in felines |
| 04/17/2008 | US20080087075 Test sensor with a side vent and method of making the same |
| 04/17/2008 | DE19948087B4 Verfahren zur Herstellung eines Reaktionssubstrats A method for producing a substrate reaction |
| 04/17/2008 | DE112006001212T5 Verfahren und Messgerät zur Messung von Wassergehalt Method and instrument for measuring water content |
| 04/17/2008 | DE112005003134T5 Elektrisch aktiver kombinatorisch-chemischer (electrically-active combinatorial-chemical; eacc) Chip zur biochemischen Analytbestimmung Electrically active combinatorial chemistry (electrically-active combinatorial-chemical; EACC) chip for biochemical analyte |
| 04/17/2008 | DE102006049682A1 Method for protein sequencing, involves elongating protein in electrical field and transporting through nano channel by electrical field |
| 04/17/2008 | DE102006023714B4 Vorrichtung und Verfahren zur selektiven Bestimmung der Menge von Ölnebel Device and method for the selective determination of the amount of oil mist |
| 04/17/2008 | DE102006022854B4 Implantierbarer Blutsauerstoffsensor Implantable blood oxygen sensor |
| 04/17/2008 | DE102006005533B4 Verbindersystem und Verfahren zum sterilen Verbinden A connector system and method for sterile connection |
| 04/17/2008 | DE102005044307B4 Ionisierung desorbierter Moleküle Ionization of desorbed molecules |
| 04/17/2008 | CA2791144A1 Protease screening methods and proteases identified thereby |
| 04/17/2008 | CA2703466A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 04/17/2008 | CA2683122A1 Therapy targeting cathepsin s |
| 04/17/2008 | CA2673569A1 A method for the determination of the oxidative stability of a lubricating fluid |
| 04/17/2008 | CA2667063A1 Biomarker for mitochondrial toxicity associated with phospholipidosis |
| 04/17/2008 | CA2666355A1 Inhibition of pde2a |
| 04/17/2008 | CA2666202A1 A method of diagnosis and agents useful for same |
| 04/17/2008 | CA2665948A1 Reliable detection of vancomycin-intermediate staphylococcus aureus |
| 04/17/2008 | CA2665709A1 Compositions and methods for treating and diagnosing irritable bowel syndrome |
| 04/17/2008 | CA2660810A1 Compositions and methods for therapy and diagnosis of cancer and cancer metastasis |
| 04/17/2008 | CA2652392A1 Culture method for obtaining a clonal population of antigen-specific b cells |
| 04/16/2008 | EP1912069A2 Method to screen ligands using eukaryotic cell display |
| 04/16/2008 | EP1912068A1 Method and system for quantification of a target compound obtained from a biological sample upon chips |
| 04/16/2008 | EP1912067A1 Method for quantification of a target compound obtained from a biological sample upon chips |
| 04/16/2008 | EP1912066A1 Auxiliary method for diagnosis and therapy of cancer with nucleolin |
| 04/16/2008 | EP1912062A1 A biosensor and chemical sensor implementation using RF and microwave device, circuits and systems |
| 04/16/2008 | EP1912054A1 Method for structuring a surface layer |
| 04/16/2008 | EP1911928A1 Apparatus and method for detecting hydrocarbons in a wellbore during drilling |
| 04/16/2008 | EP1911851A1 Compositions and methods for therapy and diagnosis of cancer and cancer metastasis |
| 04/16/2008 | EP1911768A1 Protein, method for immobilizing protein, structure, biosensor, nucleic acid, vector and kit for detecting target substance |
| 04/16/2008 | EP1911765A2 Prevention, treatment and diagnosis of diseases associated with Beta-Amyloid formation and/or aggregation |
| 04/16/2008 | EP1910844A2 Cross-beta structure binding compounds |
| 04/16/2008 | EP1910843A2 Assay |
| 04/16/2008 | EP1910842A2 A method for detecting peptides comprising a cross-beta structure |
| 04/16/2008 | EP1910841A1 In vitro process for diagnosticating neurogenerative diseases |
| 04/16/2008 | EP1910840A2 Modulation of muc1-dependent anti-estrogen resistance |
| 04/16/2008 | EP1910839A1 Colon cancer related gene tom34 |
| 04/16/2008 | EP1910838A2 Cancer specific glycans and use thereof |
| 04/16/2008 | EP1910837A2 Methods and compositions for diagnosis and treatment of influenza |
| 04/16/2008 | EP1910836A2 Potency assays for antibody drug substance binding to an fc receptor |
| 04/16/2008 | EP1910835A1 Support having nanostructured titanium dioxide film and uses thereof |
| 04/16/2008 | EP1910834A1 Apparatus assembly and method for detecting an analyte |
| 04/16/2008 | EP1910833A2 Calibration system for use with lateral flow assay test strips |
| 04/16/2008 | EP1910832A1 Assay device and method |
| 04/16/2008 | EP1910830A1 Substrate material for analyzing fluids |
| 04/16/2008 | EP1910828A2 Phosphospecific chemokine receptor antibodies |
| 04/16/2008 | EP1910827A2 Pamps, pathogen associated molecular patterns |
| 04/16/2008 | EP1910826A2 Microstructure and microdomain microarrays, methods of making and using thereof |
| 04/16/2008 | EP1910825A2 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds |
| 04/16/2008 | EP1910824A2 Methods and compositions related to determination and use of white blood cell counts |
| 04/16/2008 | EP1910823A1 Method and system for checking an electromechanical biosensor |
| 04/16/2008 | EP1910822A2 Method and apparatus for the non-invasive sensing of glucose in a human subject |
| 04/16/2008 | EP1910821A2 Biomarkers for ovarian cancer |
| 04/16/2008 | EP1910820A1 Means and method for classifying logs |
| 04/16/2008 | EP1910819A2 Continuous range hydrogen sensor |
| 04/16/2008 | EP1910818A2 Methods and apparatus for identifying live eggs |
| 04/16/2008 | EP1910799A2 Apparatus and method for detecting an analyte |
| 04/16/2008 | EP1910782A2 In-stream spectroscopic elemental analysis of particles being conducted within a gaseous stream |
| 04/16/2008 | EP1910557A2 Cancer-related genes |
| 04/16/2008 | EP1910556A1 Method and apparatus for analysing nucleic acid sequence |
| 04/16/2008 | EP1910554A2 Cyanine dyes and methods of use in biological applications |
| 04/16/2008 | EP1910553A2 Multicellular metabolic models and methods |
| 04/16/2008 | EP1910539A2 Identification of jak/stat pathway modulating genes by genome wide rnai screening |
| 04/16/2008 | EP1910419A2 Compositions and methods for the diagnosis and treatment of tumor |
| 04/16/2008 | EP1910410A2 Tuberculosis antigen detection assays and vaccines |
| 04/16/2008 | EP1909978A2 Systems and methods for capture substrates |
| 04/16/2008 | EP1909915A2 Screening method for the identification of compositions suitable for the treatment of oral cavity malodor associated with smoking a tobacco product |
| 04/16/2008 | EP1909852A2 Amyloid beta protein channel structure and uses thereof indentifying potential drug molecules for neurodegenerative diseases |
| 04/16/2008 | EP1909833A2 Methods and devices for removing pathogens and detrimental substances from bodily fluids |
| 04/16/2008 | EP1909827A2 The modulation of immunity and ceacam1 activity |
| 04/16/2008 | EP1909562A2 Methods for treating demyelination disorders |
| 04/16/2008 | EP1812793A4 Device and method for analysis of a metabolic malady |
| 04/16/2008 | EP1771582A4 Modulators of odorant receptors |
| 04/16/2008 | EP1769081A4 Method for enumerating mammalian cell micronuclei with an emphasis on differentially staining micronuclei and the chromatin of dead and dying cells |
| 04/16/2008 | EP1759206A4 Cdk9 as modifier of the igf pathway and methods of use |
| 04/16/2008 | EP1759020A4 Acacs as modifiers of the igf pathway and methods of use |
| 04/16/2008 | EP1758994A4 Aldos as modifiers of the igf pathway and methods of use |
| 04/16/2008 | EP1745287A4 Diagnosing and monitoring inflammatory diseases by measuring complement components on white blood cells |
| 04/16/2008 | EP1711819A4 Method and devices for running reactions on a target plate for maldi mass spectrometry |
| 04/16/2008 | EP1704414A4 Induction of apoptosis via arts-iap complexes |
| 04/16/2008 | EP1702204A4 Method for adjusting the quantification range of individual analytes in a multiplexed assay |
| 04/16/2008 | EP1639090A4 Compositions and methods for treating and diagnosing cancer |
| 04/16/2008 | EP1634078B1 Native analyte as reference in lateral flow assays |
| 04/16/2008 | EP1599597A4 Translucent solid matrix assay device for microarray analysis |
| 04/16/2008 | EP1594855A4 Signalling compounds for use in methods of detecting hydrogen peroxide |
| 04/16/2008 | EP1592827B1 Device comprising a microwave resonator for or on a spinner preparation machine |
| 04/16/2008 | EP1576185A4 Method for detecting mutations |
| 04/16/2008 | EP1561103B1 Separating vessel |
| 04/16/2008 | EP1499643A4 Automated sequential injection analysis systems for the determination of trace endotoxin levels |
| 04/16/2008 | EP1483582B1 Dissociative fluorescence enhancement assay |
| 04/16/2008 | EP1454133B1 Use of microwaves in the spinning industry |
| 04/16/2008 | EP1421206B1 Improved method for measuring membrane potential |
| 04/16/2008 | EP1407263B1 Method for the extra-corporeal qualitative and/or quantitative recording of neuro-toxic substances in the blood plasma of an individual |